Skip to content

A real-world study evaluating the myopia control effect of AimuHorui in children

A real-world study evaluating the myopia control effect of AimuHorui in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114864
Enrollment
Unknown
Registered
2025-12-18
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

HORI group (wear HORI lenses):None
SV group (wear SV lenses):None

Sponsors

EYE & ENT HOSPITAL OF FUDAN UNIVERSITY
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1: Age between 6 and 14 years 2: Both eyes with subjective refraction equivalent sphere (SE) -10.00D~ -0.00D, astigmatism = 0.8 (0.10 LogMAR) 4: Baseline and >=1 year axial length follow-up data

Exclusion criteria

Exclusion criteria: 1: Single eye meets the inclusion criteria 2: Systemic diseases that affect the eye's refractive power 3. Eye diseases that affect refractive errors 4. Currently undergoing other myopia control interventions such as atropine eye drops 5. Incomplete follow-up records

Design outcomes

Primary

MeasureTime frame
annual axial elongation (mm/year);

Secondary

MeasureTime frame
annual SE change (D/year);

Countries

China

Contacts

Public ContactZhi Chen

EYE & ENT HOSPITAL OF FUDAN UNIVERSITY

peter459@aliyun.com+86 21 6437 7134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026